Clinical trial
Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)
NCT00304655 · Korea Otsuka Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00304655 |
|---|---|
| Title | Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS) |
| Official title | Multicenter, Single Group Study of Aripiprazole Efficacy and Safety in the Acute Psychosis Treatment of Schizophrenia, Schizophreniform Disorder and Schizoaffective Disorder. |
| Lead sponsor | Korea Otsuka Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | Aripiprazole |
| Enrollment | 300 |
| Start date | Jul 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | Oct 1, 2007 |
| First posted | Mar 20, 2006 |
| Last update posted | Dec 17, 2009 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: